Novabiochem (San Diego, CA). Fmoc--protected olefinic amino acids ((S)--N--Fmoc--2--(4--pentenyl)alanine (Fmoc--S 5 --OH), (R)--N--Fmoc--2--(4--pentenyl)alanine (Fmoc--R 5 --OH), and (R)--N--Fmoc--2--(7--octenyl)alanine (Fmoc--R 8 --OH)) were purchased from Okeanos Tech Jiangsu Co., Ltd (Jiangsu, P.R. China). Dimethylformamide (DMF), N--methyl pyrolidinone (NMP), trifluoroacetic acid (TFA), N,N,N',N'--tetramethyl--uronium--hexafluoro--phosphate (HBTU), and piperidine were purchased from American Bioanalytical (Natick, MA). Acetic anhydride and triisopropylsilane (TIPS) were purchased from Acros Organics (Fair Lawn, NJ). Diisopropylethylamine (DIPEA) was purchased from Santa Cruz Biotechnology Inc (Santa Cruz, CA). Dexamethasone--21--thiopropionic acid (SDex) was synthesized, utilizing a protocol developed by the Kodadek laboratory 1 .
B. Manual peptide synthesis procedure. This procedure was used for molecules used in
Figures 2, 3, 4, and 5. Peptides containing unnatural, olefin side chain or α--aminoisobutyric acid (Aib) residues were synthesized on a 100 µmol scale using standard solid--phase Fmoc procedures, as described, previously. 2 For each unnatural, olefin--side chain or Aib amino acid coupling step, NMP (3 mL), Pyclock (3 eq), DIPEA (6 eq), and Fmoc--protected unnatural amino acid (3 eq) were coupled for 2 h at RT. 3 Peptides containing olefinic side chain residues to be cyclized (stapled) were cyclized as described previously. 
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Figure S1
. Structures of stapled and unstapled peptides studied in this work. 
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C. Automated peptide synthesis. This procedure was used for molecules used in Figure S6 .
N--terminally SDex--conjugated peptides were synthesized on a 100 µmol scale using standard Figure S2 . Shimadzu traces for the acetylated peptides described in this paper. 
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E. Mass spectrometry. The molecular mass of each peptide was determined by LC--MS, using a Waters XEVO Q--TOF mass spectrometer equipped with an Acquity UPLC BEH C18 1.7 um column (Milford, MA). Table S1 . Predicted and observed masses of peptides described in Figures Table S2 . Predicted and observed masses of SDex--conjugated peptides used in Figure S6 . Figure S3 . Circular dichroism spectra of peptides described in Table S2 . a Aib represents α--aminoisobutyric acid. R 8 represents (R)--2--(7ʹ′--octenyl)alanine, S 5 represents (S)--2--(4ʹ′--pentenyl)alanine, and R 5 represents (R)--2--(4ʹ′--pentenyl)alanine. All peptides were prepared with C--terminal amides and N--terminal acetyl groups. The superscripts "S" and "U" in peptides containing olefinic side--chain residues indicate that the olefinic side--chains have or have not, respectively, undergone Grubbs Catalyst I -promoted cyclization. 
II. Experimental Details

A. Cell Viability Assays
Purchased materials, cell culture method, and procedure used for cell viability experiments were described previously. 
B. Immuno Blots
Purchased materials, cell culture methods, and experimental protocol for immunoblots monitoring for EGFR, Akt, and Erk1/2 levels and phospho--activity levels, were as previously described. 
